Antenatal cell gene transfer: an immunological Trojan horse?
- 3 January 2003
- journal article
- editorial
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 1 (1) , 14-15
- https://doi.org/10.1046/j.1538-7836.2003.00074.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaquesBlood, 2002
- Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapyBlood, 2002
- Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null MutationMolecular Therapy, 2001
- Nonviral Transfer of the Gene Encoding Coagulation Factor VIII in Patients with Severe Hemophilia ANew England Journal of Medicine, 2001
- The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor developmentHaemophilia, 2001
- Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsBlood, 2001
- Oral immune tolerance induction to factor VIII via breast milk, a possibility?Haemophilia, 2000
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorNature Medicine, 1999
- Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodiesBritish Journal of Haematology, 1990